Health
New target for drug development could fill a major gap in depression treatment – News-Medical.net – Burnie Online News
Vanderbilt researchers found that ketamine’s rapid antidepressant action is due to specific synaptic effects.
THE IDEAVanderbilt researchers found that ketamine’s rapid antidepressant action is due to specific synaptic effects. This represents a new target for drug development that could fill a major gap in care for depression.The research was led by Lisa Monteggia,……
Continue Reading
-
Noosa News24 hours agoBrisbane’s new bus timetable sees journey times decrease by two minutes in first three months
-
Business22 hours agoWhat it means for shareholders
-
Noosa News22 hours agoCalls for greater education as growers in WA’s south-west brace for polyphagous shot-hole borer
-
Noosa News13 hours agoNRL legend Trevor Gillmeister charged with assaulting police officer at Brisbane pub